Carregant...
PRACTICAL RECOMMENDATIONS FOR THE USE OF SUNITINIB IN THE TREATMENT OF METASTATIC KIDNEY CANCER. ADVERSE EVENTS – POTENTIAL MARKERS OF ITS EFFICACY
The paper deals with the specific features of sunitinib tolerance in the treatment of metastatic renal-cell carcinoma. It considers in detail the drug’s side effects that are potential biomarkers of its efficacy.
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
ABV-press
2013-06-01
|
| Col·lecció: | Onkourologiâ |
| Matèries: | |
| Accés en línia: | https://oncourology.abvpress.ru/oncur/article/view/91 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|